Loading…
Loading…
Who it's for
The category: Attributable low-value-care ledger for risk-bearing providers (ACO / total cost of care); Non-Device CDS, no FDA 510(k)
Buyer map · Vol III §19.4
ACO medical director, risk-platform analytics, full-risk CFO, and associate CMO / compliance. One briefing each.
ACO / population-health medical director
Owns
Total cost of care for an attributed panel
They would say
“I know which of my physicians order too much. I can't prove it.”
ARKA sells them
The ledger
VP of analytics at a risk-enablement platform
Owns
The measurement layer across many affiliated groups
They would say
“Build vs buy — and can I defend this method to my own customers?”
ARKA sells them
The method
Full-risk medical group CFO
Owns
The margin
They would say
“Every dollar of avoidable spend is our dollar.”
ARKA sells them
The arithmetic
Associate CMO / compliance
Owns
Whether this is allowed to run
They would say
“Governance committee, AI policy, SB 1120 — show me what you will never do.”
ARKA sells them
Never-auto-deny, fire-rate ceiling, never-do list
Associate CMO · hospital medicine
A CMO, VP of Care Management, or hospital medicine chair. They own avoidable bed-days, not an attributed panel, and they do not attend the ACO meeting.
CMO, VP of Care Management, or hospital medicine chair
Owns
Avoidable bed-days — already on their dashboard
They would say
“Only 56% of in-scope orders had an expected discharge date documented when the order was placed — the gate cannot reach the rest.”
ARKA sells them
ARKA-IP — a free retrospective of the inpatient discharge gate
UM director
A VP of Utilization Management or medical director of UM. They do not attend the ACO meeting. They own the volume that gold-carding was supposed to shrink.
VP of Utilization Management / Medical Director of UM
Owns
Prior-authorisation volume and the exemption programmes that should have shrunk it
They would say
“Every other product in this space helps you win an authorisation you should not have needed. This one proves you should never have been asked.”
ARKA sells them
The qualification file — prove gold-card status once, then keep proving it
Take it with you
Download the one-page PDF for internal enablement — or use vendor-neutral evaluation criteria and the resource center for ROI, implementation, and compliance handouts.
Who it's for
The category: Attributable low-value-care ledger for risk-bearing providers (ACO / total cost of care); Non-Device CDS, no FDA 510(k)
Buyer map · Vol III §19.4
ACO medical director, risk-platform analytics, full-risk CFO, and associate CMO / compliance. One briefing each.
ACO / population-health medical director
Owns
Total cost of care for an attributed panel
They would say
“I know which of my physicians order too much. I can't prove it.”
ARKA sells them
The ledger
VP of analytics at a risk-enablement platform
Owns
The measurement layer across many affiliated groups
They would say
“Build vs buy — and can I defend this method to my own customers?”
ARKA sells them
The method
Full-risk medical group CFO
Owns
The margin
They would say
“Every dollar of avoidable spend is our dollar.”
ARKA sells them
The arithmetic
Associate CMO / compliance
Owns
Whether this is allowed to run
They would say
“Governance committee, AI policy, SB 1120 — show me what you will never do.”
ARKA sells them
Never-auto-deny, fire-rate ceiling, never-do list
Associate CMO · hospital medicine
A CMO, VP of Care Management, or hospital medicine chair. They own avoidable bed-days, not an attributed panel, and they do not attend the ACO meeting.
CMO, VP of Care Management, or hospital medicine chair
Owns
Avoidable bed-days — already on their dashboard
They would say
“Only 56% of in-scope orders had an expected discharge date documented when the order was placed — the gate cannot reach the rest.”
ARKA sells them
ARKA-IP — a free retrospective of the inpatient discharge gate
UM director
A VP of Utilization Management or medical director of UM. They do not attend the ACO meeting. They own the volume that gold-carding was supposed to shrink.
VP of Utilization Management / Medical Director of UM
Owns
Prior-authorisation volume and the exemption programmes that should have shrunk it
They would say
“Every other product in this space helps you win an authorisation you should not have needed. This one proves you should never have been asked.”
ARKA sells them
The qualification file — prove gold-card status once, then keep proving it
Take it with you
Download the one-page PDF for internal enablement — or use vendor-neutral evaluation criteria and the resource center for ROI, implementation, and compliance handouts.